Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Scheid

Showing results (71-80 of 200) with videos related to

Pageof 20
Sort By:
International Journal of Cardiology|December 28, 2010
Transmurality of scar influences the effect of a hybrid-intervention with autologous bone marrow cell injection and aortocoronary bypass surgery (MNC/CABG) in patients after myocardial infarctionJochen Müller-Ehmsen, Paschalis Tossios, Matthias Schmidt, et al.
Frontiers in Oncology|March 27, 2025
Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature reviewFrancesca Gay, Elena Zamagni, Craig Emmitt Cole, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 31, 2022
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell LymphomaDominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, et al.
Mycoses|December 23, 2020
Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysisSebastian M Wingen-Heimann, Oliver A Cornely, Maria J G T Vehreschild, et al.
The Journal of Antimicrobial Chemotherapy|June 19, 2016
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxisLena M Biehl, J Janne Vehreschild, Blasius Liss, et al.
Ejhaem|September 2, 2025
Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T CellsTim Richardson, Hishan Tharmaseelan, Guido Kobbe, et al.
BMC Cancer|August 8, 2025
Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial dataMartin Kortüm, Sebastian Theurich, James Farrell, et al.
Leukemia & Lymphoma|June 2, 2020
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effectsLina Jansen, Maximilian Merz, Monika Engelhardt, et al.
Blood Advances|July 24, 2019
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHDMadan Jagasia, Christof Scheid, Gérard Socié, et al.
European Journal of Haematology|February 24, 2015
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantationUdo Holtick, Jens-Markus Chemnitz, Alexander Shimabukuro-Vornhagen, et al.
Pageof 20

Showing results (71-80 of 200) with videos related to

Sort By:
Pageof 20
International Journal of Cardiology|December 28, 2010
Transmurality of scar influences the effect of a hybrid-intervention with autologous bone marrow cell injection and aortocoronary bypass surgery (MNC/CABG) in patients after myocardial infarctionJochen Müller-Ehmsen, Paschalis Tossios, Matthias Schmidt, et al.
Frontiers in Oncology|March 27, 2025
Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature reviewFrancesca Gay, Elena Zamagni, Craig Emmitt Cole, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 31, 2022
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell LymphomaDominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, et al.
Mycoses|December 23, 2020
Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysisSebastian M Wingen-Heimann, Oliver A Cornely, Maria J G T Vehreschild, et al.
The Journal of Antimicrobial Chemotherapy|June 19, 2016
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxisLena M Biehl, J Janne Vehreschild, Blasius Liss, et al.
Ejhaem|September 2, 2025
Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T CellsTim Richardson, Hishan Tharmaseelan, Guido Kobbe, et al.
BMC Cancer|August 8, 2025
Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial dataMartin Kortüm, Sebastian Theurich, James Farrell, et al.
Leukemia & Lymphoma|June 2, 2020
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effectsLina Jansen, Maximilian Merz, Monika Engelhardt, et al.
Blood Advances|July 24, 2019
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHDMadan Jagasia, Christof Scheid, Gérard Socié, et al.
European Journal of Haematology|February 24, 2015
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantationUdo Holtick, Jens-Markus Chemnitz, Alexander Shimabukuro-Vornhagen, et al.
Pageof 20